TEM
Tempus AI Inc.
Price performance
Sep 18, 2026About
Company activity
20 events| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 07/30 | TEM | 8-K | Tempus AI Reports Strong Q2 2026 Results and Raises Guidance | — | — | — |
| 07/20 | TEM | 8-K | Tempus AI Announces Merger Agreement with Personalis | — | — | — |
| 07/20 | TEM | 8-K | Tempus AI Announces Acquisition of Personalis to Integrate MRD Technology | — | — | — |
| 05/22 | TEM | 8-K | Tempus AI, Inc. Announces Election of Directors at 2026 Annual Meeting | — | — | — |
| 05/12 | TEM | 8-K | Tempus AI Announces $460M Convertible Senior Notes Offering | — | — | — |
| 05/05 | TEM | 8-K | Tempus AI Reports 36.1% Revenue Growth and Raises 2026 Guidance | — | — | — |
| 02/24 | TEM | 8-K | Tempus AI Reports Strong Financial Growth in 2025 and Provides 2026 Guidance | — | — | — |
| 01/12 | TEM | 8-K | Tempus AI Reports Strong Preliminary 2025 Financial Results | — | — | — |
| 11/04/25 | TEM | 8-K | Tempus AI Reports Strong Q3 2025 Results with Revenue Growth and Positive Adjusted EBITDA | — | — | — |
| 08/27/25 | TEM | 8-K | Tempus AI Announces Resale of Shares via Prospectus Supplement | — | — | — |
| 08/08/25 | TEM | 8-K | Tempus AI Reports Strong Q2 2025 Financial Results | — | — | — |
| 07/03/25 | TEM | 8-K | Tempus AI Announces $750 Million Convertible Notes Offering | — | — | — |
| 05/23/25 | TEM | 8-K | Tempus AI, Inc. Announces Annual Meeting Results | — | — | — |
| 05/06/25 | TEM | 8-K | Tempus AI Reports 75.4% Revenue Growth for Q1 2025 | — | — | — |
| 04/23/25 | TEM | 8-K | Tempus AI Announces Strategic Partnership for Oncology Model Development | — | — | — |
| 02/24/25 | TEM | 8-K | Tempus AI reports Q4 and Full Year 2024 Results with strong revenue growth | — | — | — |
| 02/03/25 | TEM | 8-K | Tempus AI, Inc. Amends Credit Agreement to Fund Acquisition of Ambry Genetics Corporation | — | — | — |
| 01/13/25 | TEM | 8-K | Tempus AI Reports Strong Preliminary 2024 Results | — | — | — |
| 11/05/24 | TEM | 8-K | Tempus AI Announces Acquisition of Ambry Genetics | — | — | — |
| 11/04/24 | TEM | 8-K | Tempus AI Reports Q3 2024 Results and Ambry Genetics Acquisition | — | — | — |
TEM filing record
Tempus AI Inc. (TEM): 20 8-K filings summarized, the most recent on Jul 30, 2026.
What the 8-K filings said
- Jul 30, 2026 · high impact
Tempus AI, Inc. reported a strong second quarter of 2026, with total revenue of $382.5 million, a 22% increase year-over-year. The company's Oncology Diagnostics segment saw a 31% growth in volume, and Data Licensing & Modeling (Insights) revenue increased by 36%. Tempus also announced the acquisition of Personalis…
Tempus AI Reports Strong Q2 2026 Results and Raises Guidance - Jul 20, 2026 · high impact
Tempus AI, Inc. has entered into a Merger Agreement with Personalis, Inc. On July 20, 2026, Tempus and Personalis agreed to a two-step merger process where Personalis will first merge with a Tempus subsidiary, followed by the surviving entity merging with another Tempus subsidiary. Personalis stockholders will receive…
Tempus AI Announces Merger Agreement with Personalis - Jul 20, 2026 · high impact
Tempus AI, Inc. has announced its agreement to acquire Personalis, Inc. for $1.5 billion, aiming to integrate Personalis's molecular residual disease (MRD) technology into its AI-enabled precision oncology platform. The acquisition, expected to close in late 2026 or early 2027, will expand Tempus's capabilities in MRD…
Tempus AI Announces Acquisition of Personalis to Integrate MRD Technology - May 22, 2026 · medium impact
Tempus AI, Inc. held its 2026 Annual Meeting of Stockholders on May 21, 2026. The meeting included the election of nine directors, ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm, and an advisory vote on the frequency of stockholder advisory votes on executive…
Tempus AI, Inc. Announces Election of Directors at 2026 Annual Meeting - May 12, 2026 · medium impact
Tempus AI, Inc. announced the completion of a private offering of $460 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032. The company used the net proceeds to repay $307.7 million of outstanding loans under its senior secured credit facilities, pay for capped call transactions, and for…
Tempus AI Announces $460M Convertible Senior Notes Offering
SEC filings in the last five years
- 18 Form 8-K
- 5 Form 10-Q
- 2 Form 10-K